Repaglinide
- Product NDC
- 72162-2558
- 11-digit product format
- 721622558
- Labeler code
- 72162
- Product ID
- 72162-2558_481210ad-ee08-453c-b79f-27f4a8777d94
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Repaglinide
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA203820
- Marketing category
- ANDA
- Marketing start
- 2014-01-22
- Substance
- REPAGLINIDE
- Active strength
- 1 mg/1
- Pharmacologic classes
- Glinide [EPC], Potassium Channel Antagonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Repaglinide
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| REPAGLINIDE | 1 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 668Z8C33LU |
| Rxcui | 200256 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 72162-2558-1 | Repaglinide | 100 in 1 BOTTLE | TABLET | 100 | | 100 |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Sample | Exclude flag | Status |
|---|
| 72162-2558-1 | 72162255801 | 100 TABLET in 1 BOTTLE (72162-2558-1) | 100 tablet | 2025-11-04 | No | No | Current |